Welcome to Multibagg AI
Log in to access personalized features
Discovery themes featuring this stockBearish
3
Neutral
4
Bullish
7
Bearish
30
Neutral
4
Bullish
12
Bearish
27
Neutral
0
Bullish
5
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Parnax Lab Limited, formerly Krishna Deep Trade & Investment Ltd, was incorporated in 1982 and is engaged in manufacturing and exporting pharmaceutical formulations.
Naxpar Pharma Private Limited, a subsidiary, has over two decades of expertise in pharmaceuticals and is acclaimed for innovation in cosmetics, herbal formulations, and nutraceuticals.
The company is recognized for its high-quality manufacturing standards, holding ISO 9002 certification from RWTUV, Germany, for its good quality systems.
Naxpar's competitive manufacturing edge includes state-of-the-art facilities located in Silvassa and Baddi, serving a diverse international clientele.
Strategically, Naxpar is poised for expansion into South East Asia, CIS, and LatAm, leveraging its WHO approval and compliance with international EHS standards.
Pharmaceuticals & Biotechnology
Pharmaceuticals
161 Cr
Moderate Risk
12.6
36.7
1.1
1.7
182.00
99.20
Sales CAGR
Profit CAGR
ROE
ROCE
Discover detailed, AI-driven financial summaries that break down key metrics, trends, and insights—empowering you to make smarter investment decisions.
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
Parnax Lab Ltd (PARNAXLAB) is currently trading at 139.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Parnax Lab Limited, formerly Krishna Deep Trade & Investment Ltd, was incorporated in 1982 and is engaged in manufacturing and exporting pharmaceutical formulations. Naxpar Pharma Private Limited, a subsidiary, has over two decades of expertise in pharmaceuticals and is acclaimed for innovation in cosmetics, herbal formulations, and nutraceuticals. The company is recognized for its high-quality manufacturing standards, holding ISO 9002 certification from RWTUV, Germany, for its good quality systems. Naxpar's competitive manufacturing edge includes state-of-the-art facilities located in Silvassa and Baddi, serving a diverse international clientele. Strategically, Naxpar is poised for expansion into South East Asia, CIS, and LatAm, leveraging its WHO approval and compliance with international EHS standards.
Over the past 52 weeks, Parnax Lab Ltd has traded between a low of ₹99.20 and a high of ₹182.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Parnax Lab Ltd has a market capitalization of approximately 160.86. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Parnax Lab Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 12.57 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 160.86 Cr, Parnax Lab Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Parnax Lab Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Parnax Lab Ltd is 12.57. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
11.40 | 167 Cr | 57.00 | 14.11 | 0.00 | 15.34 | 21.17 | 8.18 | ||
185.00 | 163 Cr | 12.47 | 2.28 | 0.00 | 18.31 | 18.42 | 13.68 | ||
139.00 | 161 Cr | 12.57 | 1.69 | 0.00 | 12.38 | 12.15 | 5.18 | ||
117.95 | 155 Cr | 14.35 | 1.10 | 0.68 | 7.69 | 9.73 | 6.30 | ||
92.95 | 152 Cr | 10.15 | 1.57 | 0.00 | 15.51 | 19.06 | 13.51 | ||
244.00 | 152 Cr | 82.68 | 3.54 | 0.00 | 4.47 | 7.31 | 1.55 | ||
147.75 | 151 Cr | — | 0.86 | 0.00 | -7.27 | -4.85 | -5.82 | ||
| Median: 7 Co. | — | 139.00 | 155 Cr | 13.46 | 1.69 | 0.00 | 12.38 | 12.15 | 6.30 |
Shareholding Pattern
Parnax Lab Ltd disclosed under Reg 29(2) that promoter Mihir Prakash Shah acquired 3,77,355 equity shares (3.28%) via off‑market inter‑se gift within the promoter/promoter group on July 22, 2026.
Shareholding Pattern
Parnax Lab Ltd disclosed (22-07-2026) that promoter Mihir Prakash Shah received 3,77,355 equity shares (3.28% of capital) via off‑market inter‑se gift within promoter group; prior holding 11,41,250 (9.94%).
Regulatory/Compliance Filing
Parnax Lab Ltd: Baiju Mahasukhlal Shah disclosed off-market inter-se gift of 3,77,355 equity shares, reducing his holding from 1,329,261 (11.57%) to 951,906 (8.29%) under Reg.29(2).
Regulatory/Compliance Filing
Parnax Lab Ltd: Baiju Mahasukhlal Shah disclosed an off-market inter-se gift of 3,77,355 equity shares (3.28%), reducing his holding from 13,29,261 (11.57%) to 9,51,906 (8.29%).
Shareholding Pattern
Parnax Lab Ltd: Disclosure under Reg 29(2) that promoter Ila B. Shah transferred (gift) 3,61,872 shares via off-market inter-se transfer; holding reduced from 13,61,872 (11.86%) to 10,00,000 (8.71%). Dated 2026-07-22.
Shareholding Pattern
Parnax Lab Ltd disclosure: promoter Ila B. Shah gifted/disposed 361,872 shares (3.15%), reducing holdings from 1,361,872 (11.86%) to 1,000,000 (8.71%). Dated July 22, 2026.
